These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

238 related items for PubMed ID: 9876614

  • 1. Effect of glycine/citric acid on the dissolution stability of hard gelatin capsules.
    Adesunloye TA, Stach PE.
    Drug Dev Ind Pharm; 1998 Jun; 24(6):493-500. PubMed ID: 9876614
    [Abstract] [Full Text] [Related]

  • 2. Stability studies of the effect of crosslinking on hydrochlorothiazide release.
    Elmeshad AN, Darwish MK.
    Drug Discov Ther; 2009 Jun; 3(3):136-42. PubMed ID: 22495541
    [Abstract] [Full Text] [Related]

  • 3. [Evaluation of correlation between gelatin crosslinking indicators and influence factors].
    Liu JP, Ma X, Zhu JB.
    Yao Xue Xue Bao; 2005 Mar; 40(3):279-84. PubMed ID: 15952604
    [Abstract] [Full Text] [Related]

  • 4. The impact of formulation and process changes on in vitro dissolution and the bioequivalence of piroxicam capsules.
    Piscitelli DA, Bigora S, Propst C, Goskonda S, Schwartz P, Lesko LJ, Augsburger L, Young D.
    Pharm Dev Technol; 1998 Nov; 3(4):443-52. PubMed ID: 9834946
    [Abstract] [Full Text] [Related]

  • 5. Influence of capsule shell composition on the performance indicators of hypromellose capsule in comparison to hard gelatin capsules.
    Al-Tabakha MM, Arida AI, Fahelelbom KM, Sadek B, Saeed DA, Abu Jarad RA, Jawadi J.
    Drug Dev Ind Pharm; 2015 Nov; 41(10):1726-37. PubMed ID: 25586554
    [Abstract] [Full Text] [Related]

  • 6. Solid-state interaction of stearic acid with povidone and its effect on dissolution stability of capsules.
    Desai D, Kothari S, Huang M.
    Int J Pharm; 2008 Apr 16; 354(1-2):77-81. PubMed ID: 18194844
    [Abstract] [Full Text] [Related]

  • 7. Crosslinking studies in gelatin capsules treated with formaldehyde and in capsules exposed to elevated temperature and humidity.
    Ofner CM, Zhang YE, Jobeck VC, Bowman BJ.
    J Pharm Sci; 2001 Jan 16; 90(1):79-88. PubMed ID: 11064381
    [Abstract] [Full Text] [Related]

  • 8. Performance qualification of a new hypromellose capsule: part I. Comparative evaluation of physical, mechanical and processability quality attributes of Vcaps Plus, Quali-V and gelatin capsules.
    Sherry Ku M, Li W, Dulin W, Donahue F, Cade D, Benameur H, Hutchison K.
    Int J Pharm; 2010 Feb 15; 386(1-2):30-41. PubMed ID: 19900518
    [Abstract] [Full Text] [Related]

  • 9. Development of a two-step tier-2 dissolution method for blinded overencapsulated erlotinib tablets using UV fiber optic detection.
    Lu X, Xiao B, Lo L, Bolgar MS, Lloyd DK.
    J Pharm Biomed Anal; 2011 Aug 25; 56(1):23-9. PubMed ID: 21620602
    [Abstract] [Full Text] [Related]

  • 10. Challenges and opportunities in the encapsulation of liquid and semi-solid formulations into capsules for oral administration.
    Cole ET, Cadé D, Benameur H.
    Adv Drug Deliv Rev; 2008 Mar 17; 60(6):747-56. PubMed ID: 18096270
    [Abstract] [Full Text] [Related]

  • 11. [A review on liquid-filled hard gelatin capsules].
    Ma JH, Yang M, Zeng M, Chen XM, Lan J.
    Zhongguo Zhong Yao Za Zhi; 2008 Mar 17; 33(5):602-5. PubMed ID: 18536390
    [Abstract] [Full Text] [Related]

  • 12. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam.
    Prabhu S, Ortega M, Ma C.
    Int J Pharm; 2005 Sep 14; 301(1-2):209-16. PubMed ID: 16046087
    [Abstract] [Full Text] [Related]

  • 13. Comparison of WHO and US FDA biowaiver dissolution test conditions using bioequivalent doxycycline hyclate drug products.
    Strauch S, Jantratid E, Dressman JB.
    J Pharm Pharmacol; 2009 Mar 14; 61(3):331-7. PubMed ID: 19222905
    [Abstract] [Full Text] [Related]

  • 14. Enhancing the Dissolution Stability of Hard Gelatin Capsules Using Activated Carbon as a Packaging Component.
    Likar MD, Carroll SC, Colgan ST, Yeoh T, MacDonald BC, Johnson GM, Space JS.
    J Pharm Sci; 2018 Dec 14; 107(12):3080-3088. PubMed ID: 30145210
    [Abstract] [Full Text] [Related]

  • 15. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
    Karataş A, Bekmezci S.
    Acta Pol Pharm; 2013 Dec 14; 70(5):883-97. PubMed ID: 24147368
    [Abstract] [Full Text] [Related]

  • 16. Effect of fill weight, capsule shell, and sinker design on the dissolution behavior of capsule formulations of a weak acid drug candidate BMS-309403.
    Wu Y, Zhao F, Paborji M.
    Pharm Dev Technol; 2003 Dec 14; 8(4):379-83. PubMed ID: 14601962
    [Abstract] [Full Text] [Related]

  • 17. Stabilization of hard gelatin capsule shells filled with polyethylene glycol matrices.
    Stein D, Bindra DS.
    Pharm Dev Technol; 2007 Dec 14; 12(1):71-7. PubMed ID: 17484146
    [Abstract] [Full Text] [Related]

  • 18. In vitro/in vivo evaluation of hydrochlorothiazide in experimental hydrochlorothiazide/triamterene combination tablets in beagle dogs.
    Ritschel WA, Turkoglu M, Lipps D, Warner A, Sakr A.
    Arzneimittelforschung; 1991 Mar 14; 41(3):208-11. PubMed ID: 1867656
    [Abstract] [Full Text] [Related]

  • 19. Use of texture analysis to study hydrophilic solvent effects on the mechanical properties of hard gelatin capsules.
    Mei X, Etzler FM, Wang Z.
    Int J Pharm; 2006 Nov 06; 324(2):128-35. PubMed ID: 16844327
    [Abstract] [Full Text] [Related]

  • 20. Investigations into the use of pregelatinised starch to develop powder-filled hard capsules.
    Gohil UC, Podczeck F, Turnbull N.
    Int J Pharm; 2004 Nov 05; 285(1-2):51-63. PubMed ID: 15488679
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.